Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early- and mid-stage human healthcare and life science companies. We target the entire healthcare and biotechnology industry, with a special focus on pharmaceuticals, diagnostics and medical devices. Founded in 2008, Ysios Capital has over € 200 million in assets under management through its two funds: Ysios BioFund I (€65 M) and Ysios BioFund II Innvierte (€ 126M). We aim to create value by providing talented entrepreneurs with the resources and tools to achieve success in transforming intellectual capital and scientific knowledge into successful companies. Our team includes experienced professionals with extensive complementary expertise in investing and building healthcare and biotechnology companies.
52
Total Investments
33
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Ysios Capital
Recent Investments (52)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Late Vc | •••••• | Apr 2025 | |
| B | •••••• | Nov 2024 | |
| Series A | •••••• | May 2024 | |
| Series C | •••••• | May 2024 | |
| Series B | •••••• | Mar 2024 | |
|
|
Series A | •••••• | Nov 2023 |
|
|
Series D | •••••• | Aug 2023 |
|
|
Series A | •••••• | Jun 2023 |
|
|
Series B | •••••• | May 2023 |
|
|
Series B | •••••• | Sep 2022 |
Latest News
Spain’s Acurio Ventures launches €115 million vehicle to provide liquidity to European VC funds
Eu-startups · Jul 13, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.